
Damon Dierker, OD, FAAO, shares latest updates in research on sutureless cryopreserved amniotic membrane for moderate-to-severe dry eye with short treatment duration.
Dr. Dierker has helped to create a comprehensive ocular surface disease service within his practice that incorporates the latest diagnostic and therapeutic advances to serve his patients. He is active in developing innovative strategies to help colleagues

Damon Dierker, OD, FAAO, shares latest updates in research on sutureless cryopreserved amniotic membrane for moderate-to-severe dry eye with short treatment duration.



Similar to the benefits that the primary care and pediatrics fields have enjoyed following years of rapid strep and flu testing, the uptake of rapid, single-use, point-of-care (POC) testing in optometry helps to guide clinical management and therapeutic decisions.

Published: August 28th 2020 | Updated:

Published: August 28th 2020 | Updated:

Published: May 19th 2017 | Updated: